IL9 and systemic sclerosis: The DVSMCs were incubated with IL-9, IL-9, and IL-9 neutralizing antibodies, IL-9 and tanshinone IIA, SSc serum, SSc serum and IL-9 neutralizing antibodies, and SSc serum and tanshinone IIA for 3 days.